Basit öğe kaydını göster

dc.contributor.authorDuz, Muhammed Emin
dc.contributor.authorBalci, Aydin
dc.contributor.authorMenekse, Elif
dc.contributor.authorOzturk, Alpaslan
dc.date.accessioned2024-03-12T19:34:25Z
dc.date.available2024-03-12T19:34:25Z
dc.date.issued2021
dc.identifier.issn0393-6384
dc.identifier.issn2283-9720
dc.identifier.urihttps://doi.org/10.19193/0393-6384_2021_6_507
dc.identifier.urihttps://hdl.handle.net/20.500.12450/2554
dc.description.abstractIntroduction: Although the increase in cardiac troponins (cTn) in COVID-19 patients has gained importance in the literature, the mechanism of increase has not been fully elucidated. However, it has been a matter of debate whether the rise in cTn has significance in terms of the acute coronary syndrome (ACS) in COVID-19 patients. Our study aims to shed light on these points. Materials and methods: This retrospective study includes 179 patients, 64% male, mean age 64.6, with COVID-19 disease and without ACS or myocardial infarction (MI). Demographic, clinical, and laboratory variables were provided from medical records. The cTn measurements of outpatients were made on the day of admission, the measurements of the patients who were hospitalized in the service were made on the third day after the admission, the measurements of the discharged patients were made between the 9th and 11th days after the admission, and the measurements of the patients admitted to the intensive care unit were made between the 13th and 15th days following the admission. Results: While the cTnI values on the third day of hospitalization were significantly higher than the first examination values, the cTnI values of the discharged patients (mean: 0.18 ug/L) were significantly lower than the values on the third day of admission (mean: 0.33 ug/L) and hospitalization (mean: 0.24 ug/L). ICU patients had significantly higher cTnI values (mean: 0.57 ug/L) than other cTnI measurements ((mean: 0.24 ug/L), (mean: 0.33 ug/L), (mean: 0.18 ug/L)). ECG data of the patients were insignificant in terms of ACS or MI, and no complaints or physical examination findings due to typical cardiac pathologies were found in any patient. The coronary angiographic procedure was not applied to any patient. Conclusion: It is meaningful to check cTn for the first examination and follow-up in COVID-19 patients. On the other hand, in COVID-19 patients who do not clinically comply with the ACS or MI picture, cTn increases do not provide sufficient contribution for ACS and planned interventional procedures. However, it should not be forgotten that each cTn increase has a vital value and must be investigated.en_US
dc.language.isoengen_US
dc.publisherCarbone Editoreen_US
dc.relation.ispartofActa Medica Mediterraneaen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSARS-CoV-2en_US
dc.subjectCOVID-19en_US
dc.subjectTroponinen_US
dc.subjectAcute Coronary Syndromeen_US
dc.subjectCoronavirusen_US
dc.subjectMyocardial Infarctionen_US
dc.titleCLINICAL UNCERTAINTIES OF CARDIAC TROPONIN INTERPRETATION AMONG COVID-19en_US
dc.typearticleen_US
dc.departmentAmasya Üniversitesien_US
dc.authoridDUZ, Muhammed Emin/0000-0002-1837-6415
dc.identifier.volume37en_US
dc.identifier.issue6en_US
dc.identifier.startpage3221en_US
dc.identifier.endpage3225en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-85120406146en_US
dc.identifier.doi10.19193/0393-6384_2021_6_507
dc.department-temp[Duz, Muhammed Emin; Menekse, Elif; Ozturk, Alpaslan] Amasya Univ, Sabuncuoglu Serefeddin Training & Res Hosp, Med Biochem, Amasya, Turkey; [Balci, Aydin] Afyonkarahisar Hlth Sci Univ, Med Fac, Dept Pulmonol, Afyon, Turkeyen_US
dc.identifier.wosWOS:000792666700012en_US
dc.authorwosidDUZ, Muhammed Emin/ABF-4918-2020


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster